Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $5.69 Million - $7.75 Million
188,500 New
188,500 $6.81 Million
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $7.16 Million - $9.34 Million
176,200 Added 362.55%
224,800 $10.5 Million
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $1.46 Million - $2.77 Million
35,686 Added 276.34%
48,600 $2.13 Million
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $774,194 - $1.19 Million
12,914 New
12,914 $934,000
Q4 2021

Feb 14, 2022

SELL
$81.07 - $121.29 $9.02 Million - $13.5 Million
-111,228 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$101.99 - $166.36 $11.3 Million - $18.5 Million
111,228 New
111,228 $12.9 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.